7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 
      
                           
      operating activities
                           
      net income
    494,000,000 436,000,000 373,000,000 401,000,000 382,000,000 392,000,000 334,000,000 189,000,000 430,000,000 478,000,000 511,000,000 653,000,000 636,000,000 364,000,000 420,000,000 530,000,000 530,000,000 648,000,000 611,000,000 456,000,000 314,000,000 253,000,000 34,000,000 
      adjustments to reconcile net income to net change due to operating activities:
                           
      benefit for credit losses
    154,000,000 164,000,000 153,000,000 162,000,000 172,000,000 182,000,000 171,000,000 171,000,000 172,000,000 176,000,000 168,000,000 132,000,000 123,000,000 216,000,000 3,000,000         
      net change in loans held for sale
    216,000,000 35,000,000 -332,000,000       -370,000,000 -81,000,000 329,000,000 184,000,000 322,000,000 898,000,000 462,000,000 301,000,000 944,000,000 -622,000,000     
      depreciation, amortization, and accretion
    119,000,000                       
      deferred income tax expense
    22,000,000 -99,000,000 -16,000,000 -127,000,000 -18,000,000   -181,000,000 -21,000,000               
      share-based compensation
    23,000,000 43,000,000 31,000,000 21,000,000 21,000,000 21,000,000 34,000,000 14,000,000 18,000,000 22,000,000 33,000,000 16,000,000 16,000,000 19,000,000 33,000,000 12,000,000 12,000,000 13,000,000 22,000,000 14,000,000 11,000,000 2,000,000 21,000,000 
      net gain on sale of assets
    -2,000,000 -5,000,000 -9,000,000 -4,000,000 -9,000,000 -5,000,000                 
      net increase in other assets
    -2,000,000 325,000,000 34,000,000 -247,000,000 -291,000,000 324,000,000 -47,000,000 1,344,000,000 95,000,000 -455,000,000 -372,000,000 -194,000,000 1,645,000,000 -2,129,000,000 -1,216,000,000 674,000,000 -264,000,000       
      net increase in other liabilities
    672,000,000 -137,000,000 -570,000,000 239,000,000 -233,000,000 -110,000,000 -206,000,000 -1,057,000,000 -279,000,000 148,000,000 849,000,000 459,000,000 229,000,000 -1,052,000,000 1,400,000,000 -76,000,000 586,000,000       
      net change due to operating activities
    1,696,000,000 886,000,000 -213,000,000 483,000,000 130,000,000 834,000,000 554,000,000 670,000,000 1,008,000,000 125,000,000 1,158,000,000 1,441,000,000 3,000,000,000 -1,876,000,000 1,554,000,000 1,105,000,000 1,280,000,000       
      investing activities
                           
      investment securities:
                           
      purchases of debt securities available for sale
    -1,420,000,000 -1,760,000,000 -2,365,000,000 -3,258,000,000 -2,010,000,000 -1,430,000,000 -3,057,000,000 -4,511,000,000 -2,370,000,000 -1,983,000,000 -1,223,000,000 -1,004,000,000 -1,134,000,000 -5,982,000,000 -2,656,000,000 -3,737,000,000 -2,256,000,000 -2,157,000,000 -4,256,000,000     
      proceeds from maturities and paydowns of debt securities available for sale
    961,000,000 963,000,000 846,000,000 1,192,000,000 794,000,000 725,000,000 593,000,000 520,000,000 552,000,000 506,000,000 423,000,000 579,000,000 679,000,000 961,000,000 1,203,000,000 1,751,000,000 1,738,000,000 2,040,000,000 2,281,000,000 2,360,000,000 2,062,000,000 1,511,000,000 1,010,000,000 
      proceeds from sales of debt securities available for sale
    101,000,000 475,000,000 642,000,000 1,539,000,000 1,377,000,000 11,000,000 692,000,000 512,000,000 797,000,000 237,000,000 1,395,000,000 121,000,000 353,000,000 704,000,000 632,000,000 54,000,000 50,000,000 54,000,000 537,000,000    
      proceeds from maturities and paydowns of debt securities held to maturity
    189,000,000 198,000,000 150,000,000 161,000,000 177,000,000 174,000,000 150,000,000 164,000,000 228,000,000 187,000,000 182,000,000 263,000,000 270,000,000 312,000,000 190,000,000 254,000,000 222,000,000 289,000,000 241,000,000 268,000,000 280,000,000 218,000,000 131,000,000 
      net increase in interest-bearing deposits in banks
    -14,000,000 5,000,000 -50,000,000 13,000,000 -89,000,000 -167,000,000 13,000,000 -81,000,000 -40,000,000 36,000,000 -17,000,000 -42,000,000 208,000,000 216,000,000 -369,000,000 -27,000,000 112,000,000 -93,000,000 -2,000,000     
      purchases of loans
    -139,000,000 -315,000,000 -188,000,000 -138,000,000 -77,000,000 -95,000,000 -345,000,000     -28,000,000 -261,000,000 -718,000,000         
      sales of loans
    517,000,000 671,000,000 240,000,000 21,000,000 61,000,000 18,000,000 107,000,000 165,000,000 293,000,000 2,020,000,000 315,000,000 959,000,000 1,301,000,000 112,000,000 305,000,000         
      net increase in loans and leases
    -1,654,000,000 -1,502,000,000 -319,000,000 2,190,000,000 29,000,000 958,000,000 2,873,000,000 3,384,000,000 1,131,000,000 1,963,000,000 696,000,000 -990,000,000 -322,000,000 -4,419,000,000 -2,196,000,000 -2,793,000,000 -881,000,000       
      capital expenditures
    -35,000,000 -33,000,000 -14,000,000 -48,000,000 -34,000,000 -30,000,000 -10,000,000 -48,000,000 -33,000,000 -39,000,000 -52,000,000 15,000,000 -85,000,000 -5,000,000 -51,000,000 -65,000,000 -27,000,000 -22,000,000 -10,000,000 -119,000,000    
      free cash flows
                      -700,000,000     
      other
    -3,000,000 -130,000,000 -50,000,000 -64,000,000 -67,000,000 15,000,000 23,000,000 120,000,000 -176,000,000 222,000,000 -227,000,000 -39,000,000 -5,000,000 -644,000,000 -83,000,000 -119,000,000 -82,000,000 -68,000,000 -47,000,000     
      net change due to investing activities
    -1,497,000,000 -1,428,000,000 -1,108,000,000 1,608,000,000 161,000,000 179,000,000 1,039,000,000 225,000,000 382,000,000 3,149,000,000 1,492,000,000 -158,000,000 883,000,000 -9,448,000,000 -3,914,000,000 -7,499,000,000 -1,284,000,000       
      financing activities
                           
      net increase in deposits
    4,925,000,000 -2,490,000,000 2,800,000,000 -412,000,000 -1,164,000,000 -76,000,000 -914,000,000 -855,000,000 530,000,000 5,473,000,000 -8,530,000,000 2,158,000,000 -359,000,000 -68,000,000 4,415,000,000 2,140,000,000 1,585,000,000 -713,000,000 4,185,000,000  -697,000,000 10,143,000,000 8,162,000,000 
      net increase in short-term borrowed funds
    -35,000,000 202,000,000 47,000,000 -15,000,000 13,000,000 -7,000,000 -496,000,000 273,000,000 -867,000,000 81,000,000 1,015,000,000 -269,000,000 -3,500,000,000 3,726,000,000 -52,000,000 86,000,000 -57,000,000 -7,000,000 -176,000,000    780,000,000 
      proceeds from issuance of long-term borrowed funds
    501,000,000 3,500,000,000 2,533,000,000 2,332,000,000 5,088,000,000 5,765,000,000 4,750,000,000 9,016,000,000 6,507,000,000 5,710,000,000 13,101,000,000 6,299,000,000        14,000,000 1,509,000,000 6,800,000,000 
      repayments of long-term borrowed funds
    -2,594,000,000 -3,251,000,000 -2,675,000,000 -1,545,000,000 -1,485,000,000 -5,819,000,000 -5,437,000,000 -8,652,000,000 -5,762,000,000 -11,252,000,000 -2,752,000,000 -13,501,000,000 -4,434,000,000 -752,000,000 -1,004,000,000 4,000,000 1,000,000 -1,353,000,000 -4,000,000     
      treasury stock purchased
    -75,000,000 -200,000,000 -200,000,000 -225,000,000 -325,000,000 -200,000,000 -300,000,000    -151,000,000   -200,000,000 -95,000,000     
      net proceeds from issuance of preferred stock
       1,000,000                
      redemption of preferred stock
                         
      dividends paid to common stockholders
    -184,000,000 -185,000,000 -186,000,000 -188,000,000 -190,000,000 -194,000,000 -197,000,000 -199,000,000 -199,000,000 -205,000,000 -205,000,000      -167,000,000 -168,000,000 -167,000,000     
      dividends paid to preferred stockholders
    -33,000,000 -33,000,000 -34,000,000 -38,000,000 -35,000,000 -30,000,000 -31,000,000 -31,000,000 -32,000,000 -24,000,000 -33,000,000      -33,000,000 -23,000,000 -32,000,000     
      net change due to financing activities
    2,903,000,000 -2,451,000,000 2,261,000,000 -2,405,000,000 -1,147,000,000 -841,000,000 -1,622,000,000 -4,667,000,000 2,443,000,000 319,000,000 -5,223,000,000 1,104,000,000 -2,237,000,000 7,902,000,000 3,138,000,000 1,836,000,000 1,079,000,000       
      net change in cash and cash equivalents
    3,102,000,000 -2,993,000,000 940,000,000 -314,000,000 -856,000,000 172,000,000 -29,000,000 -3,772,000,000 3,833,000,000 3,593,000,000 -2,573,000,000 2,387,000,000 1,646,000,000 -3,422,000,000 778,000,000 -4,558,000,000 1,075,000,000       
      cash and cash equivalents at beginning of period
    10,601,000,000 11,628,000,000 10,547,000,000 9,158,000,000 12,733,000,000  3,386,000,000 
      cash and cash equivalents at end of period
    3,102,000,000 -2,993,000,000 11,541,000,000 -314,000,000 -856,000,000 172,000,000 11,599,000,000 -3,772,000,000 3,833,000,000 3,593,000,000 7,974,000,000 2,387,000,000 1,646,000,000 -3,422,000,000 9,936,000,000 -4,558,000,000 1,075,000,000 -2,019,000,000 14,660,000,000  1,770,000,000 3,388,000,000 4,058,000,000 
      non-cash items:
                           
      transfer of loans from loans held for investment to lhfs
    21,000,000 42,000,000 1,876,000,000                     
      loans securitized and transferred to afs securities
        48,000,000                   
      depreciation, amortization and accretion
      123,000,000 124,000,000 129,000,000 143,000,000 102,000,000 126,000,000 122,000,000 112,000,000 118,000,000 117,000,000 121,000,000 260,000,000 67,000,000 172,000,000 136,000,000 165,000,000 152,000,000 154,000,000 103,000,000 109,000,000 201,000,000 
      acquisitions, net of cash acquired
               -20,000,000 -1,000,000 -91,000,000 -143,000,000 -151,000,000        
      purchases of bank-owned life insurance
                           
      net change in loans held for sale, at fair value
        -23,000,000 -86,000,000 171,000,000 73,000,000                
      transfer of loans from loans held for investment to loans held for sale
        34,000,000 108,000,000 107,000,000                 
      adjustments to reconcile net income to net change in cash due to operating activities:
                           
      premium paid to exchange debt
                           
      net gain on sales of assets
            -5,000,000 -9,000,000 -5,000,000  -1,000,000 -4,000,000         
      purchase of bank-owned life insurance
                -100,000,000  -150,000,000 -125,000,000 -375,000,000     
      payments of employee tax withholding for share-based compensation
            -2,000,000 -24,000,000 -1,000,000 -1,000,000 -23,000,000 -1,000,000 -21,000,000     
      transfer of loans from portfolio to lhfs
            181,000,000               
      transfer of securities from available for sale to held to maturity
                753,000,000           
      investors acquisition:
                           
      fair value of assets acquired, excluding cash and cash equivalents
                -69,000,000           
      goodwill and other intangible assets
                78,000,000           
      fair value of liabilities assumed
                9,000,000           
      common stock issued
                          
      replacement equity awards
                          
      treasury stock purchased, including excise tax
             -259,000,000 -404,000,000             
      deferred income taxes
              -63,000,000 -67,000,000 46,000,000 125,000,000 -47,000,000 -643,000,000 15,000,000 119,000,000 80,000,000     
      dividends declared and paid to common stockholders
               -210,000,000 -209,000,000 -195,000,000 -165,000,000         
      dividends declared and paid to preferred stockholders
               -23,000,000 -34,000,000 -23,000,000 -33,000,000         
      benefit from credit losses
                   -25,000,000 -33,000,000 -213,000,000 -140,000,000 124,000,000 428,000,000 464,000,000 600,000,000 
      supplemental disclosures:
                           
      interest paid
                           
      income taxes paid
                           
      transfer of securities from held to maturity to available for sale
                           
      loans securitized and transferred to securities available for sale
                           
      loans securitized and transferred to securities held to maturity
                           
      stock issued for share-based compensation plans
                           
      stock issued for employee stock purchase plan
                           
      net gain on sales of:
                           
      debt securities
                    -3,000,000       
      premises and equipment
                          
      premium paid to exchange subordinated debt
                    -1,000,000     
      adjustments to reconcile net income to net cash from operating activities:
                           
      net gain on sale of debt securities
                      -3,000,000     
      increase in other assets
                      -773,000,000     
      decrease in other liabilities
                      -17,000,000     
      net cash from operating activities
                      -690,000,000     
      net decrease (increase) in loans and leases
                      1,042,000,000     
      net cash from investing activities
                      -1,072,000,000     
      net cash from financing activities
                      3,689,000,000  -988,000,000 2,305,000,000 10,767,000,000 
      increase in cash and cash equivalents
                      1,927,000,000  1,770,000,000 3,388,000,000 672,000,000 
      amortization of intangibles
                       5,000,000 3,000,000 3,000,000 
      increase in other liabilities
                       432,000,000 270,000,000   
      net decrease in equity securities, at fair value
                           
      net decrease in equity securities, at cost
                        2,000,000   
      net decrease in short-term borrowed funds
                           
      net increase in equity securities, at fair value
                           
      net increase in equity securities, at cost
                           
      net decrease (increase) in interest-bearing deposits in banks
                          17,000,000 
      originations of mortgage loans held for sale
                           
      proceeds from sales of mortgage loans held for sale
                           
      purchases of commercial loans held for sale
                           
      proceeds from sales of commercial loans held for sale
                           
      mortgage servicing rights valuation charge-off
                           
      debt securities impairment
                           
      equity securities
                           
      other loans held for sale
                           
      purchases of securities available for sale
                           
      purchases of debt securities held to maturity
                           
      purchases of equity securities, at fair value
                           
      proceeds from sales of equity securities, at fair value
                           
      purchases of equity securities, at cost
                           
      proceeds from sales of equity securities, at cost
                           
      purchases of mortgage servicing rights
                           
      net increase in bank-owned life insurance
                           
      premises and equipment:
                           
      purchases
                           
      proceeds from sales
                           
      capitalization of software
                           
      net decrease in federal funds purchased and securities sold under agreements to repurchase
                           
      net increase in other short-term borrowed funds
                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.